scholarly journals Monitoring Trends in Prenatal Diagnosis of Down's Syndrome in England and Wales, 1989–92

1994 ◽  
Vol 1 (4) ◽  
pp. 233-237 ◽  
Author(s):  
Joan K Morris ◽  
David E Mutton ◽  
Roy Ide ◽  
Eva Alberman ◽  
Martin Bobrow

The national register of chromosomal anomalies that lead to Down's syndrome has enabled the monitoring of change in prenatal diagnosis for this condition, and the factors which affect the change. The proportion of cases of cytogenetically diagnosed Down's syndrome in England and Wales detected prenatally rose to 46% in 1991–2 from 31% in 1988–9, a 1·5-fold increase (95% confidence interval 1·3 to 1·7). The increase was confined to mothers under 40 years and was due to the introduction of screening by maternal serum analysis and ultrasound. Over a quarter of affected pregnancies in women aged 25–29 were detected prenatally in 1991–2 compared with less than 10% in 1988–9. Analysis of the data showed regional differences in prenatal diagnosis rates, and in the length of time elapsing between the diagnostic test and termination of an affected pregnancy. An inexplicable finding was that this period varied with the sex of the fetus, being on average a day longer for females than for males.

1990 ◽  
Vol 85 (3) ◽  
pp. 362-366 ◽  
Author(s):  
Tomas Porstmann ◽  
Roselotte Wietschke ◽  
Günther Cobet ◽  
Katja Lorenz ◽  
Roland Grunow ◽  
...  

Author(s):  
Angela Ballantyne ◽  
Lorna Rashid ◽  
Rebecca Pattenden

Background Maternal serum free beta human chorionic gonadotrophin (free β-hCG) is used as a biomarker in first trimester screening for fetal Down’s syndrome. Production of free β-hCG can occur in vitro in a time- and temperature-dependent manner; thus, the current Scottish screening protocol states samples must be received by the laboratory within 72 h. To assess the validity of the protocol, an audit was conducted to determine the impact of transit time on maternal serum free β-hCG multiple of median (MoM) values in the Scottish screened population. Methods Corrected MoM values from antenatal screening carried out over one year (April 2017 to March 2018) were stratified according to sample transit time and compared. To investigate possible environmental temperature effects, the data were split according to season and maternal serum free β-hCG concentrations from summer and winter compared. Results Of the 28,368 samples included in the study, 24,368 were received on the day of phlebotomy or after one day in transit. Only 1.5% of samples were received after 3 days in transit. The difference in maternal serum free β-hCG MoM values due to transit time was not significant. No statistical difference was found between maternal serum free β-hCG concentrations from samples collected in summer and winter months. Conclusion The current sample receipt protocol in use by the Scottish Down’s syndrome screening programme is fit for purpose.


Author(s):  
J. A. CANICK ◽  
G. J. KNIGHT ◽  
G. E. PALOMAK1 ◽  
J. E. HADDOW ◽  
H. S. CUCKLE ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document